Azienda Ospedaliera Universitaria, Policlinico Tor Vergata

Roma 133

0 studies enrolling now · 13 studies all time

What they study most

Advanced Solid Tumor and Lymphoma Malignancies, Anemia, Breast Cancer, Crohn Disease, Diverticulitis, Gastric, or Gastroesophageal Junction Adenocarcinoma, Hepatitis Delta Virus, Multiple Sclerosis, Narcolepsy, Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), Relapsing Forms of Multiple Sclerosis

Studies at this site

• A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy — Completed
• A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) — Completed
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed
• A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
• Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a — Completed
• A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies — Completed
• Prevention of Recurrence of Diverticulitis — Completed
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis — Completed
• Long-Term Safety Of PF-00547659 In Ulcerative Colitis — Completed
• Oral Cladribine in Early Multiple Sclerosis (MS) — Completed
• A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q — Completed